December 15th, 2009 Biogen threatens proxy fight in Facet bidNEW YORK — Biotechnology company Biogen Idec Inc. threatened a proxy fight Tuesday to remove a majority of Facet Biotech Corp.'s directors, heating up an already volatile ...
The final step in the acquisition process was a short-form merger of Amber Acquisition Inc., a wholly-owned subsidiary of Abbott, with and into Facet Biotech Corporation. As a result of the merger, all outstanding shares of Facet common ...
ABBOTT PARK, Illinois, April 21, 2010 - Abbott (NYSE: ABT) has completed its acquisition of Facet Biotech.
Little Facet Biotech (FACT) had to put up with some awfully patronizing statements from Biogen Idec (BIIB) when the big biotech was waging a $438 mill.
Facet Biotech Corporation (NASDAQ: FACT) is a buyout saga that seemed as though it would never end in 2009. The company is now finally being acquired, but not by Biogen Idec (NASDAQ: BIIB). Abbott Laboratories (NYSE: ABT) announced last ...
The following is a round-up of news likely to affect stock prices today: Facet Biotech (FACT) shares soared over 67% in premarket trading after it agreed to be acquired by Abbott Laboratories (ABT) for $722 million, or $27 a share.
Under the terms of the agreement, Abbott will promptly commence a tender offer to purchase all outstanding shares of Facet Biotech at $27 per share. The closing of the tender offer is conditioned on the tender of a majority of the ...
CALIFORNIA (GaeaTimes.com)- In a move that may have an impact on the future of biotechnology and medical research, Abbott Laboratories is going to acquire noted biotechnology products developer Facet Biotech Corp.
Abbott has succeeded where Biogen Idec once failed. The company announced late Tuesday that it's purchasing Facet Biotech for $450 million, or $27 a share. That's 67 percent premium over the... Read more...
Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of $450 million in cash, in a move aimed at expanding its drug pipeline, including for treatments for multiple sclerosis.
